(TESB) Tessenderlo - Ratings and Ratios

Tessenderlo Group NV is a diversified industrial conglomerate with a broad portfolio of businesses operating globally, leveraging its expertise in agriculture, bio-residual valorization, machinery, mechanical engineering, electronics, energy, and industrial solutions. The companys diverse segments cater to various industries, including agriculture, food, pharmaceuticals, mining, construction, and consumer goods, among others.

The Agro segment is a significant player in the production and marketing of specialty fertilizers and crop protection products, with brands such as Thio-Sul, KTS, and MAJOR90. The Bio-Valorization segment is a leading producer of gelatins, collagen peptides, and proteins, serving the food, pharmaceutical, and other industries. The Industrial Solutions segment provides a range of products and services, including preassembled piping kits, coagulants, and industrial chemicals, to various sectors. The Machines & Technologies segment designs and manufactures weaving machines, casting solutions, and customized controllers, while the T-Power segment generates electricity through a 425 MW combined cycle gas turbine.

With a market capitalization of 1620.66M EUR and a forward P/E ratio of 13.04, Tessenderlos stock is currently trading at 26.00 EUR, slightly below its 52-week high of 26.42 EUR. The stock has shown a relatively stable trend, with a 20-day SMA of 25.92 EUR and a 50-day SMA of 25.11 EUR. The ATR of 0.56 EUR indicates a moderate level of volatility.

Based on the technical and fundamental data, a forecast for Tessenderlos stock can be made. With the current price above its 20-day and 50-day SMAs, and the forward P/E ratio indicating a potential for earnings growth, the stock is likely to continue its upward trend. However, the relatively high P/E ratio of 38.36 and the moderate volatility indicated by the ATR suggest that the stock may face some resistance at higher price levels. A potential target price could be around 28-30 EUR, representing a 7-15% increase from the current price, assuming the company continues to deliver on its earnings growth prospects and the overall market conditions remain favorable.